Search

everythinglearnresearchcommunity

for

Search:↓

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

The new drug delivery system effectively targets lung cancer cells.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

Compound 1 showed promising anticancer activity.

The drug combination was safe and showed promise in treating advanced tumors.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Stevioside-based microneedles improve minoxidil delivery for effective hair growth treatment.

Clofazimine effectively treated ashy dermatosis in a patient.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Enzyme purified and characterized for minoxidil sulphation in rat liver.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Stevioside-based microneedles improve minoxidil delivery and hair growth for treating hair loss.